Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O60721
UPID:
NCKX1_HUMAN
Alternative names:
Na(+)/K(+)/Ca(2+)-exchange protein 1; Retinal rod Na-Ca+K exchanger; Solute carrier family 24 member 1
Alternative UPACC:
O60721; O43485; O75184; Q17RM9
Background:
Sodium/potassium/calcium exchanger 1, also known as Na(+)/K(+)/Ca(2+)-exchange protein 1, plays a pivotal role in the visual transduction cascade by regulating calcium concentration in the outer segments of retinal rod and cone photoreceptors. This regulation is crucial for light adaptation, with the protein facilitating the extrusion of calcium in response to light exposure, thereby modulating photoreceptor sensitivity.
Therapeutic significance:
The protein's malfunction is linked to Night blindness, congenital stationary, 1D, a disorder characterized by impaired night vision without progression. Understanding the role of Sodium/potassium/calcium exchanger 1 could open doors to potential therapeutic strategies for this and related visual impairments.